$CBRE
CBRE GROUP, INC.

2016 Q2 Form 10-Q Financial Statement

#000119312516676274 Filed on August 09, 2016

View on sec.gov

Income Statement

Concept 2016 Q2 2015 Q2
Revenue $3.208B $2.391B
YoY Change 34.18% 12.4%
Cost Of Revenue $27.18M $1.488B
YoY Change -98.17% 13.2%
Gross Profit $3.180B $902.5M
YoY Change 252.38% 11.1%
Gross Profit Margin 99.15% 37.75%
Selling, General & Admin $680.4M $610.2M
YoY Change 11.5% 7.77%
% of Gross Profit 21.39% 67.61%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $90.30M $70.70M
YoY Change 27.72% 11.69%
% of Gross Profit 2.84% 7.83%
Operating Expenses $680.4M $610.2M
YoY Change 11.52% 7.76%
Operating Profit $182.6M $228.8M
YoY Change -20.18% 11.04%
Interest Expense $36.99M $26.15M
YoY Change 41.42% -8.13%
% of Operating Profit 20.26% 11.43%
Other Income/Expense, Net $3.882M -$1.069M
YoY Change -463.14% -116.8%
Pretax Income $187.5M $209.6M
YoY Change -10.56% 7.88%
Income Tax $64.04M $76.47M
% Of Pretax Income 34.16% 36.48%
Net Earnings $121.7M $125.0M
YoY Change -2.69% 18.55%
Net Earnings / Revenue 3.79% 5.23%
Basic Earnings Per Share $0.36 $0.38
Diluted Earnings Per Share $0.36 $0.37
COMMON SHARES
Basic Shares Outstanding 335.1M shares 332.0M shares
Diluted Shares Outstanding 338.1M shares 336.2M shares

Balance Sheet

Concept 2016 Q2 2015 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $432.0M $406.0M
YoY Change 6.4% -10.38%
Cash & Equivalents $431.8M $336.4M
Short-Term Investments $70.00M
Other Short-Term Assets $230.8M $104.2M
YoY Change 121.52% 23.03%
Inventory
Prepaid Expenses $199.3M $154.5M
Receivables $2.373B $1.605B
Other Receivables $941.0M $800.0M
Total Short-Term Assets $4.246B $3.343B
YoY Change 27.02% 0.13%
LONG-TERM ASSETS
Property, Plant & Equipment $533.6M $484.0M
YoY Change 10.24% 6.31%
Goodwill $3.061B $2.314B
YoY Change 32.29% -0.91%
Intangibles $1.396B $806.1M
YoY Change 73.21% -1.29%
Long-Term Investments $226.7M $281.0M
YoY Change -19.31% 1.08%
Other Assets $351.2M $197.6M
YoY Change 77.73% 13.34%
Total Long-Term Assets $5.676B $4.117B
YoY Change 37.87% -0.39%
TOTAL ASSETS
Total Short-Term Assets $4.246B $3.343B
Total Long-Term Assets $5.676B $4.117B
Total Assets $9.923B $7.460B
YoY Change 33.01% -0.15%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.382B $765.0M
YoY Change 80.65% -0.65%
Accrued Expenses $1.231B $999.0M
YoY Change 23.22% 11.62%
Deferred Revenue
YoY Change
Short-Term Debt $995.3M $744.5M
YoY Change 33.69% -30.68%
Long-Term Debt Due $42.55M $13.89M
YoY Change 206.22% -67.18%
Total Short-Term Liabilities $3.743B $2.595B
YoY Change 44.24% -9.78%
LONG-TERM LIABILITIES
Long-Term Debt $2.625B $1.711B
YoY Change 53.4% -3.72%
Other Long-Term Liabilities $476.5M $320.4M
YoY Change 48.72% -0.75%
Total Long-Term Liabilities $3.101B $2.032B
YoY Change 52.66% -3.26%
TOTAL LIABILITIES
Total Short-Term Liabilities $3.743B $2.595B
Total Long-Term Liabilities $3.101B $2.032B
Total Liabilities $7.019B $4.957B
YoY Change 41.6% -6.43%
SHAREHOLDERS EQUITY
Retained Earnings $2.292B $1.759B
YoY Change 30.3% 43.05%
Common Stock $1.135B $1.071B
YoY Change 5.97% 5.63%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $2.855B $2.460B
YoY Change
Total Liabilities & Shareholders Equity $9.923B $7.460B
YoY Change 33.01% -0.15%

Cashflow Statement

Concept 2016 Q2 2015 Q2
OPERATING ACTIVITIES
Net Income $121.7M $125.0M
YoY Change -2.69% 18.55%
Depreciation, Depletion And Amortization $90.30M $70.70M
YoY Change 27.72% 11.69%
Cash From Operating Activities $118.6M $137.7M
YoY Change -13.87% 199.35%
INVESTING ACTIVITIES
Capital Expenditures -$45.60M -$31.80M
YoY Change 43.4% -20.3%
Acquisitions
YoY Change
Other Investing Activities $4.700M -$32.20M
YoY Change -114.6% -177.78%
Cash From Investing Activities -$40.80M -$64.00M
YoY Change -36.25% -4366.67%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -130.8M -120.1M
YoY Change 8.91% 23.05%
NET CHANGE
Cash From Operating Activities 118.6M 137.7M
Cash From Investing Activities -40.80M -64.00M
Cash From Financing Activities -130.8M -120.1M
Net Change In Cash -53.00M -46.40M
YoY Change 14.22% -7.39%
FREE CASH FLOW
Cash From Operating Activities $118.6M $137.7M
Capital Expenditures -$45.60M -$31.80M
Free Cash Flow $164.2M $169.5M
YoY Change -3.13% 97.32%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2016Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
335618448 shares
CY2015Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
336422000
CY2015Q2 us-gaap Fair Value Liabilities Level2 To Level1 Transfers Amount
FairValueLiabilitiesLevel2ToLevel1TransfersAmount
0
CY2015Q2 us-gaap Fair Value Assets Level1 To Level2 Transfers Amount
FairValueAssetsLevel1ToLevel2TransfersAmount
0
CY2015Q2 us-gaap Fair Value Assets Level2 To Level1 Transfers Amount
FairValueAssetsLevel2ToLevel1TransfersAmount
0
CY2015Q2 us-gaap Fair Value Liabilities Level1 To Level2 Transfers Amount
FairValueLiabilitiesLevel1ToLevel2TransfersAmount
0
CY2016Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
728021000
CY2016Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2016Q2 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
46530000
CY2016Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2016Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
335575365 shares
CY2016Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
335575365 shares
CY2016Q2 us-gaap Assets
Assets
9922572000
CY2016Q2 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
107709000
CY2016Q2 us-gaap Assets Current
AssetsCurrent
4246081000
CY2016Q2 us-gaap Accrued Bonuses Current
AccruedBonusesCurrent
502766000
CY2016Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
525000000 shares
CY2016Q2 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
1131881000
CY2016Q2 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
45685000
CY2016Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
431768000
CY2016Q2 us-gaap Fair Value Liabilities Level2 To Level1 Transfers Amount
FairValueLiabilitiesLevel2ToLevel1TransfersAmount
0
CY2016Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
2373157000
CY2016Q2 us-gaap Common Stock Value
CommonStockValue
3356000
CY2016Q2 us-gaap Equity Method Investments
EquityMethodInvestments
226742000
CY2016Q2 us-gaap Fair Value Assets Level1 To Level2 Transfers Amount
FairValueAssetsLevel1ToLevel2TransfersAmount
0
CY2016Q2 us-gaap Fair Value Assets Level2 To Level1 Transfers Amount
FairValueAssetsLevel2ToLevel1TransfersAmount
0
CY2016Q2 us-gaap Fair Value Liabilities Level1 To Level2 Transfers Amount
FairValueLiabilitiesLevel1ToLevel2TransfersAmount
0
CY2016Q2 us-gaap Accounts Payable And Other Accrued Liabilities Current
AccountsPayableAndOtherAccruedLiabilitiesCurrent
1381802000
CY2016Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-572181000
CY2016Q2 us-gaap Deferred Tax Assets Liabilities Net Noncurrent
DeferredTaxAssetsLiabilitiesNetNoncurrent
107709000
CY2016Q2 us-gaap Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
85034000
CY2016Q2 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
2624977000
CY2016Q2 us-gaap Long Term Debt
LongTermDebt
2696126000
CY2016Q2 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
676848000
CY2016Q2 us-gaap Long Term Debt Current
LongTermDebtCurrent
42546000
CY2016Q2 us-gaap Other Assets Current
OtherAssetsCurrent
230805000
CY2016Q2 us-gaap Other Short Term Borrowings
OtherShortTermBorrowings
16000
CY2016Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
1396240000
CY2016Q2 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
45673000
CY2016Q2 us-gaap Liabilities
Liabilities
7018802000
CY2016Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
9922572000
CY2016Q2 us-gaap Goodwill
Goodwill
3061024000
CY2016Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
476517000
CY2016Q2 us-gaap Liabilities Current
LiabilitiesCurrent
3742649000
CY2016Q2 us-gaap Loans Receivable Held For Sale Net Not Part Of Disposal Group Mortgage
LoansReceivableHeldForSaleNetNotPartOfDisposalGroupMortgage
847700000
CY2016Q2 us-gaap Minority Interest
MinorityInterest
48652000
CY2016Q2 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
199299000
CY2016Q2 us-gaap Investments In Affiliates Subsidiaries Associates And Joint Ventures
InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
226742000
CY2016Q2 us-gaap Letters Of Credit Outstanding Amount
LettersOfCreditOutstandingAmount
48000000
CY2016Q2 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
92838000
CY2016Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
351201000
CY2016Q2 us-gaap Liability For Uncertain Tax Positions Noncurrent
LiabilityForUncertainTaxPositionsNoncurrent
89625000
CY2016Q2 us-gaap Lines Of Credit Current
LinesOfCreditCurrent
156000000
CY2016Q2 us-gaap Loans Receivable Mortgage Warehouse Lending
LoansReceivableMortgageWarehouseLending
130700000
CY2016Q2 us-gaap Other Long Term Debt
OtherLongTermDebt
47000
CY2016Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
533575000
CY2016Q2 us-gaap Stockholders Equity
StockholdersEquity
2855118000
CY2016Q2 us-gaap Short Term Borrowings
ShortTermBorrowings
995311000
CY2016Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
2903770000
CY2016Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
2292062000
CY2016Q2 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
70502000
CY2016Q2 us-gaap Unamortized Debt Issuance Expense
UnamortizedDebtIssuanceExpense
28603000
CY2016Q2 us-gaap Warehouse Agreement Borrowings
WarehouseAgreementBorrowings
839295000
CY2016Q2 cbg Commitments To Investment In Future Real Estate Investment
CommitmentsToInvestmentInFutureRealEstateInvestment
36500000
CY2016Q2 cbg Loan Loss Sharing Reserve
LoanLossSharingReserve
23400000
CY2016Q2 cbg Coverage Ratio Of Earnings Before Interest Tax Depreciation And Amortization To Interest Expense
CoverageRatioOfEarningsBeforeInterestTaxDepreciationAndAmortizationToInterestExpense
12.15 pure
CY2016Q2 cbg Guarantor Obligations Maximum Exposure Undiscounted
GuarantorObligationsMaximumExposureUndiscounted
55000000
CY2016Q2 cbg Loan Receivable Mortgage Warehouse Lending Current
LoanReceivableMortgageWarehouseLendingCurrent
847712000
CY2016Q2 cbg Leverage Ratio Of Debt To Earnings Before Interest Tax Depreciation And Amortization
LeverageRatioOfDebtToEarningsBeforeInterestTaxDepreciationAndAmortization
1.61 pure
CY2016Q2 cbg Long Term Debt Excluding Loans Payable
LongTermDebtExcludingLoansPayable
2624977000
CY2016Q2 cbg Commitments To Investment In Unconsolidated Entity
CommitmentsToInvestmentInUnconsolidatedEntity
28600000
CY2016Q2 cbg Assets Available For Recourse
AssetsAvailableForRecourse
300600000
CY2014Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
740884000
CY2015Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
705070000
CY2015Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2015Q4 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
82194000
CY2015Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2015Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
334230496 shares
CY2015Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
334230496 shares
CY2015Q4 us-gaap Assets
Assets
11017943000
CY2015Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
135252000
CY2015Q4 us-gaap Assets Current
AssetsCurrent
5305223000
CY2015Q4 us-gaap Accrued Bonuses Current
AccruedBonusesCurrent
866894000
CY2015Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
525000000 shares
CY2015Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
1106758000
CY2015Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
46606000
CY2015Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
540403000
CY2015Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
2471740000
CY2015Q4 us-gaap Common Stock Value
CommonStockValue
3342000
CY2015Q4 us-gaap Equity Method Investments
EquityMethodInvestments
217943000
CY2015Q4 us-gaap Accounts Payable And Other Accrued Liabilities Current
AccountsPayableAndOtherAccruedLiabilitiesCurrent
1484119000
CY2015Q4 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
59331000
CY2015Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
293236000
CY2015Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-485675000
CY2015Q4 us-gaap Deferred Tax Assets Liabilities Net Noncurrent
DeferredTaxAssetsLiabilitiesNetNoncurrent
135252000
CY2015Q4 us-gaap Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
100361000
CY2015Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
2645111000
CY2015Q4 us-gaap Long Term Debt
LongTermDebt
2710438000
CY2015Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
589236000
CY2015Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
34428000
CY2015Q4 us-gaap Other Assets Current
OtherAssetsCurrent
220956000
CY2015Q4 us-gaap Other Short Term Borrowings
OtherShortTermBorrowings
16000
CY2015Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
1450469000
CY2015Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
70655000
CY2015Q4 us-gaap Liabilities
Liabilities
8258873000
CY2015Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
11017943000
CY2015Q4 us-gaap Goodwill
Goodwill
3085997000
CY2015Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
430577000
CY2015Q4 us-gaap Liabilities Current
LiabilitiesCurrent
4994157000
CY2015Q4 us-gaap Loans Receivable Held For Sale Net Not Part Of Disposal Group Mortgage
LoansReceivableHeldForSaleNetNotPartOfDisposalGroupMortgage
1800000000
CY2015Q4 us-gaap Minority Interest
MinorityInterest
46418000
CY2015Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
172922000
CY2015Q4 us-gaap Investments In Affiliates Subsidiaries Associates And Joint Ventures
InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
217943000
CY2015Q4 us-gaap Liability For Uncertain Tax Positions Noncurrent
LiabilityForUncertainTaxPositionsNoncurrent
88667000
CY2015Q4 us-gaap Other Long Term Debt
OtherLongTermDebt
63000
CY2015Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
529823000
CY2015Q4 us-gaap Stockholders Equity
StockholdersEquity
2712652000
CY2015Q4 us-gaap Short Term Borrowings
ShortTermBorrowings
1750797000
CY2015Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
2759070000
CY2015Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
2088227000
CY2015Q4 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
72764000
CY2015Q4 us-gaap Unamortized Debt Issuance Expense
UnamortizedDebtIssuanceExpense
30899000
CY2015Q4 us-gaap Warehouse Agreement Borrowings
WarehouseAgreementBorrowings
1750781000
CY2015Q4 cbg Loan Loss Sharing Reserve
LoanLossSharingReserve
21800000
CY2015Q4 cbg Loan Receivable Mortgage Warehouse Lending Current
LoanReceivableMortgageWarehouseLendingCurrent
1767107000
CY2015Q4 cbg Long Term Debt Excluding Loans Payable
LongTermDebtExcludingLoansPayable
2645111000
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
7264000
us-gaap Equity Method Investment Summarized Financial Information Revenue
EquityMethodInvestmentSummarizedFinancialInformationRevenue
600040000
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-404462000
us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
-10965000
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.66
us-gaap Equity Method Investment Summarized Financial Information Net Income Loss
EquityMethodInvestmentSummarizedFinancialInformationNetIncomeLoss
-178808000
us-gaap Depreciation And Amortization
DepreciationAndAmortization
140451000
us-gaap Payments To Acquire Business Two Net Of Cash Acquired
PaymentsToAcquireBusinessTwoNetOfCashAcquired
94975000
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.65
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
171252000
us-gaap Costs And Expenses
CostsAndExpenses
4061135000
us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
8309000
us-gaap Cost Of Services
CostOfServices
2778751000
us-gaap Equity Method Investment Dividends Or Distributions
EquityMethodInvestmentDividendsOrDistributions
13174000
us-gaap Proceeds From Sale Of Securities Operating Activities
ProceedsFromSaleOfSecuritiesOperatingActivities
35596000
us-gaap Revenues
Revenues
4443009000
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Before Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax
-47912000
us-gaap Interest Paid
InterestPaid
43123000
us-gaap Gain Loss On Sale Of Other Assets
GainLossOnSaleOfOtherAssets
74135000
us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
219000
us-gaap Incremental Common Shares Attributable To Contingently Issuable Shares
IncrementalCommonSharesAttributableToContingentlyIssuableShares
3678940 shares
us-gaap Other Comprehensive Income Unrealized Gain Loss On Derivatives Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax
-2511000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
18000
us-gaap Proceeds From Minority Shareholders
ProceedsFromMinorityShareholders
4405000
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-4971000
us-gaap Payments To Acquire Interest In Joint Venture
PaymentsToAcquireInterestInJointVenture
27571000
us-gaap Operating Expenses
OperatingExpenses
1141933000
us-gaap Net Income Loss
NetIncomeLoss
217966000
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
8325000
us-gaap Payments For Proceeds From Tenant Allowance
PaymentsForProceedsFromTenantAllowance
-6262000
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
4412000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
359668000
us-gaap Interest Expense
InterestExpense
52368000
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-170837000
us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
22225000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-113769000
us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
831000000
us-gaap Proceeds From Equity Method Investment Dividends Or Distributions Return Of Capital
ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital
27269000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
43118000
us-gaap Proceeds From Sale Of Mortgage Servicing Rights Msr
ProceedsFromSaleOfMortgageServicingRightsMSR
12615000
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-46730000
us-gaap Operating Income Loss
OperatingIncomeLoss
388860000
us-gaap Payments To Acquire Available For Sale Securities
PaymentsToAcquireAvailableForSaleSecurities
23453000
us-gaap Gains Losses On Sales Of Investment Real Estate
GainsLossesOnSalesOfInvestmentRealEstate
6986000
us-gaap Increase Decrease In Income Taxes Receivable
IncreaseDecreaseInIncomeTaxesReceivable
14125000
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
-180469000
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
71000
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-9767000
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
148011000
us-gaap Investment Income Interest
InvestmentIncomeInterest
3699000
us-gaap Payments For Purchase Of Securities Operating Activities
PaymentsForPurchaseOfSecuritiesOperatingActivities
42653000
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
5113000
us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
-390333000
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
22144000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
133377000
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-42191000
us-gaap Other Comprehensive Income Other Net Of Tax
OtherComprehensiveIncomeOtherNetOfTax
18000
us-gaap Proceeds From Sale Of Available For Sale Securities
ProceedsFromSaleOfAvailableForSaleSecurities
24563000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
50388000
us-gaap Increase Decrease In Restricted Cash
IncreaseDecreaseInRestrictedCash
38678000
us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
179561000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
335926626 shares
us-gaap Reclassification From Accumulated Other Comprehensive Income Current Period Net Of Tax
ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
-3604000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
331988489 shares
us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
18000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
3214000
us-gaap Proceeds From Short Term Debt
ProceedsFromShortTermDebt
569000
us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-1836000
us-gaap Proceeds From Repayments Of Short Term Debt
ProceedsFromRepaymentsOfShortTermDebt
569000
us-gaap Profit Loss
ProfitLoss
226291000
us-gaap Write Off Of Deferred Debt Issuance Cost
WriteOffOfDeferredDebtIssuanceCost
2685000
us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
835512000
us-gaap Share Based Compensation
ShareBasedCompensation
29132000
us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
17278000
us-gaap Payments To Minority Shareholders
PaymentsToMinorityShareholders
10637000
cbg Proceeds From Notes Payable On Real Estate Held For Sale And Under Development
ProceedsFromNotesPayableOnRealEstateHeldForSaleAndUnderDevelopment
4404000
cbg Equity Method Investment Summarized Financial Information Operating Profit Loss
EquityMethodInvestmentSummarizedFinancialInformationOperatingProfitLoss
-24747000
cbg Income Loss Before Net Interest Expense Write Off Of Financing Costs Income Taxes Depreciation And Amortization
IncomeLossBeforeNetInterestExpenseWriteOffOfFinancingCostsIncomeTaxesDepreciationAndAmortization
543148000
cbg Incremental Common Shares Attributable To Stock Options
IncrementalCommonSharesAttributableToStockOptions
259197 shares
cbg Proceeds From Senior Term Loans
ProceedsFromSeniorTermLoans
500000000
cbg Repayments Of Senior Term Loans
RepaymentsOfSeniorTermLoans
648738000
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
5204000
dei Entity Registrant Name
EntityRegistrantName
CBRE GROUP, INC.
dei Document Type
DocumentType
10-Q
dei Entity Central Index Key
EntityCentralIndexKey
0001138118
us-gaap Basis Of Accounting
BasisOfAccounting
<div> <table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" border="0" cellpadding="0" cellspacing="0" width="100%"> <tr> <td width="4%" valign="top" align="left"><b>1.</b></td> <td align="left" valign="top"><b>Basis of Presentation</b></td> </tr> </table> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"> Readers of this Quarterly Report on Form 10-Q (Quarterly Report) should refer to the audited financial statements and notes to consolidated financial statements of CBRE Group, Inc., a Delaware corporation (which may be referred to in these financial statements as the &#x201C;Company,&#x201D; &#x201C;we,&#x201D; &#x201C;us&#x201D; and &#x201C;our&#x201D;), for the year ended December 31, 2015, which are included in our 2015 Annual Report on Form 10-K (2015 Annual Report), filed with the United States Securities and Exchange Commission (SEC) and also available on our website (www.cbre.com), since we have omitted from this Quarterly Report certain footnote disclosures which would substantially duplicate those contained in such audited financial statements.&#xA0;You should also refer to Note 2, Significant Accounting Policies, in the notes to consolidated financial statements in our 2015 Annual Report for further discussion of our significant accounting policies and estimates.</p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"> The accompanying consolidated financial statements have been prepared in accordance with the rules applicable to quarterly reports on Form 10-Q and include all information and footnotes required for interim financial statement presentation, but do not include all disclosures required under accounting principles generally accepted in the United States (GAAP) for annual financial statements.&#xA0;In our opinion, all adjustments (consisting of normal recurring adjustments, except as otherwise noted) considered necessary for a fair presentation have been included.&#xA0;The preparation of financial statements in conformity with GAAP requires us to make estimates and assumptions about future events.&#xA0;These estimates and the underlying assumptions affect the amounts of assets and liabilities reported, and reported amounts of revenue and expenses.&#xA0;Such estimates include the value of goodwill, intangibles and other long-lived assets, real estate assets, accounts receivable, investments in unconsolidated subsidiaries and assumptions used in the calculation of income taxes, retirement and other post-employment benefits, among others.&#xA0;These estimates and assumptions are based on our best judgment.&#xA0;We evaluate our estimates and assumptions on an ongoing basis using historical experience and other factors, including consideration of the current economic environment, and adjust such estimates and assumptions when facts and circumstances dictate.&#xA0;As future events and their effects cannot be determined with precision, actual results could differ significantly from these estimates.&#xA0;Changes in these estimates resulting from continuing changes in the economic environment will be reflected in the financial statements in future periods.&#xA0;Certain reclassifications have been made to the 2015 financial statements to conform with the 2016 presentation.</p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"> The results of operations for the three and six months ended June 30, 2016 are not necessarily indicative of the results of operations to be expected for the year ending December 31, 2016.</p> </div>
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
28554000
dei Document Period End Date
DocumentPeriodEndDate
2016-06-30
us-gaap Equity Method Investment Summarized Financial Information Revenue
EquityMethodInvestmentSummarizedFinancialInformationRevenue
582494000
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-108635000
us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
-588000
us-gaap Description Of New Accounting Pronouncements Not Yet Adopted
DescriptionOfNewAccountingPronouncementsNotYetAdopted
<div> <table style="FONT-SIZE: 10pt; FONT-FAMILY: 'Times New Roman'; WORD-SPACING: 0px; BORDER-COLLAPSE: collapse; TEXT-TRANSFORM: none; WIDOWS: 1; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px" cellspacing="0" cellpadding="0" width="100%" border="0"> <tr> <td valign="top" width="4%" align="left"><b>2.</b></td> <td valign="top" align="left"><b>New Accounting Pronouncements</b></td> </tr> </table> <p style="MARGIN-BOTTOM: 0pt; WHITE-SPACE: normal; WORD-SPACING: 0px; TEXT-TRANSFORM: none; COLOR: rgb(0,0,0); FONT: 10pt 'Times New Roman'; MARGIN-LEFT: 75px; WIDOWS: 1; MARGIN-TOP: 6pt; LETTER-SPACING: normal; TEXT-INDENT: 0px; -webkit-text-stroke-width: 0px"> <i>Recent Accounting Pronouncements Pending Adoption</i></p> <p style="MARGIN-BOTTOM: 0pt; WHITE-SPACE: normal; WORD-SPACING: 0px; TEXT-TRANSFORM: none; COLOR: rgb(0,0,0); FONT: 10pt 'Times New Roman'; WIDOWS: 1; MARGIN-TOP: 6pt; LETTER-SPACING: normal; TEXT-INDENT: 4%; -webkit-text-stroke-width: 0px"> The Financial Accounting Standards Board (FASB) has recently issued four Accounting Standards Updates (ASUs) related to revenue recognition, all of which become effective for the Company on January 1, 2018.&#xA0;The ASUs issued are: (1) in May 2014, ASU 2014-09,&#xA0;<i>&#x201C;Revenue from Contracts with Customers (Topic 606);&#x201D;&#xA0;</i>(2) in March 2016, ASU 2016-08,&#xA0;<i>&#x201C;Revenue from Contracts with Customers (Topic 606): Principal versus Agent Considerations (Reporting Revenue Gross versus Net);&#x201D;</i>&#xA0;(3) in April 2016, ASU 2016-10,&#xA0;<i>&#x201C;Revenue from Contracts with Customers (Topic 606): Identifying Performance Obligations and Licensing;&#x201D;&#xA0;</i>and (4) in May 2016, ASU 2016-12,<i>&#x201C;Revenue from Contracts with Customers (Topic 606): Narrow-scope Improvements and Practical Expedients.&#x201D;&#xA0;</i>ASU 2014-09 requires an entity to recognize the amount of revenue to which it expects to be entitled for the transfer of promised goods or services to customers and will replace most existing revenue recognition guidance under GAAP.&#xA0;This ASU permits the use of either the retrospective or cumulative effect transition method.&#xA0;We are evaluating the effect that ASU 2014-09 will have on our consolidated financial statements and related disclosures.&#xA0;We have not yet selected a transition method nor have we determined the effect of this ASU on our ongoing financial reporting.&#xA0;ASU 2016-08 clarifies the implementation guidance on principal versus agent considerations.&#xA0;We are evaluating the effect that ASU 2016-08 will have on our consolidated financial statements and related disclosures.&#xA0;ASU 2016-10 clarifies guidance related to identifying performance obligations and licensing implementation guidance contained in ASU 2014-09.&#xA0;ASU 2016-12 clarifies guidance in certain narrow areas and adds some practical expedients.&#xA0;We do not believe the application of ASU 2016-10 and ASU 2016-12 will have a material impact on our consolidated financial statements and related disclosures.</p> <p style="MARGIN-BOTTOM: 0pt; WHITE-SPACE: normal; WORD-SPACING: 0px; TEXT-TRANSFORM: none; COLOR: rgb(0,0,0); FONT: 10pt 'Times New Roman'; WIDOWS: 1; MARGIN-TOP: 12pt; LETTER-SPACING: normal; TEXT-INDENT: 4%; -webkit-text-stroke-width: 0px"> In January 2016, the FASB issued ASU 2016-01,&#xA0;<i>&#x201C;Financial Instruments&#x2014;Overall (Subtopic 825-10): Recognition and Measurement of Financial Assets and Financial Liabilities.&#x201D;</i>&#xA0;This ASU will significantly change the income statement impact of equity investments and the recognition of changes in fair value of financial liabilities when the fair value option is elected.&#xA0;This ASU is effective for fiscal years, and interim periods within those years, beginning after December 15, 2017.&#xA0;Early adoption is not permitted, except for the provisions related to the recognition of changes in fair value of financial liabilities when the fair value option is elected.&#xA0;We do not believe the adoption of ASU 2016-01 will have a material impact on our consolidated financial statements and related disclosures.</p> <p style="MARGIN-BOTTOM: 0pt; WHITE-SPACE: normal; WORD-SPACING: 0px; TEXT-TRANSFORM: none; COLOR: rgb(0,0,0); FONT: 10pt 'Times New Roman'; WIDOWS: 1; MARGIN-TOP: 12pt; LETTER-SPACING: normal; TEXT-INDENT: 4%; -webkit-text-stroke-width: 0px"> In February 2016, the FASB issued ASU 2016-02,&#xA0;<i>&#x201C;Leases (Topic 842).&#x201D;&#xA0;</i>This ASU requires lessees to recognize most leases on-balance sheet and mandates a modified retrospective transition method for all entities.&#xA0;This ASU is effective for annual periods in fiscal years beginning after December 15, 2018.&#xA0;We are evaluating the effect that ASU 2016-02 will have on our consolidated financial statements and related disclosures.</p> <p style="MARGIN-BOTTOM: 0pt; WHITE-SPACE: normal; WORD-SPACING: 0px; TEXT-TRANSFORM: none; COLOR: rgb(0,0,0); FONT: 10pt 'Times New Roman'; WIDOWS: 1; MARGIN-TOP: 12pt; LETTER-SPACING: normal; TEXT-INDENT: 4%; -webkit-text-stroke-width: 0px"> In March 2016, the FASB issued ASU 2016-05,&#xA0;<i>&#x201C;Effect of Derivative Contract Novations on Existing Hedge Accounting Relationships.&#x201D;</i>&#xA0;This ASU clarifies that a change in one of the parties to a derivative contract (through novation) that is part of a hedge accounting relationship does not, by itself, require designation of that relationship, as long as all other hedge accounting criteria continue to be met.&#xA0;This ASU is effective for annual and interim periods in fiscal years beginning after December 15, 2016, with early adoption permitted.&#xA0;We do not believe the adoption of ASU 2016-05 will have a material impact on our consolidated financial statements and related disclosures.</p> <p style="MARGIN-BOTTOM: 0pt; WHITE-SPACE: normal; WORD-SPACING: 0px; TEXT-TRANSFORM: none; COLOR: rgb(0,0,0); FONT: 10pt 'Times New Roman'; WIDOWS: 1; MARGIN-TOP: 12pt; LETTER-SPACING: normal; TEXT-INDENT: 4%; -webkit-text-stroke-width: 0px"> In March 2016, the FASB issued ASU 2016-07,&#xA0;<i>&#x201C;Simplifying the Transition to the Equity Method of Accounting.&#x201D;&#xA0;</i>This ASU eliminates the requirement for an investor to retroactively apply the equity method when its increase in ownership interest (or degree of influence) in an investee triggers equity method accounting.&#xA0;ASU 2016-07 should be applied prospectively upon its effective date to increases in the level of ownership interest or degree of influence that result in the adoption of the equity method.&#xA0;This ASU is effective for all entities for interim and annual periods in fiscal years beginning after December 15, 2016, with early application permitted.&#xA0;We do not believe the application of ASU 2016-07 will have a material impact on our consolidated financial statements and related disclosures.</p> <p style="MARGIN-BOTTOM: 0pt; WHITE-SPACE: normal; WORD-SPACING: 0px; TEXT-TRANSFORM: none; COLOR: rgb(0,0,0); FONT: 10pt 'Times New Roman'; WIDOWS: 1; MARGIN-TOP: 12pt; LETTER-SPACING: normal; TEXT-INDENT: 4%; -webkit-text-stroke-width: 0px"> In March 2016, the FASB issued ASU 2016-09,&#xA0;<i>&#x201C;Improvements to Employee Share-Based Payment Accounting.&#x201D;&#xA0;</i>This ASU is intended to improve the accounting for share-based payment transactions as part of the FASB&#x2019;s simplification initiative. This ASU is effective for fiscal years beginning after December 15, 2016, and interim periods within those years, with early adoption permitted. We are evaluating the effect that ASU 2016-09 will have on our consolidated financial statements and related disclosures.</p> <p style="MARGIN-BOTTOM: 0pt; WHITE-SPACE: normal; WORD-SPACING: 0px; TEXT-TRANSFORM: none; COLOR: rgb(0,0,0); FONT: 10pt 'Times New Roman'; WIDOWS: 1; MARGIN-TOP: 12pt; LETTER-SPACING: normal; TEXT-INDENT: 4%; -webkit-text-stroke-width: 0px"> In June 2016, the FASB issued ASU 2016-13,&#xA0;<i>&#x201C;Financial Instruments&#x2014;Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments.&#x201D;&#xA0;</i>This ASU is intended to improve financial reporting by requiring timelier recording of credit losses on loans and other financial instruments held by financial institutions and other organizations. This ASU is effective for fiscal years beginning after December 15, 2019, and interim periods within those years, with early adoption permitted.&#xA0;We are evaluating the effect that ASU 2016-13 will have on our consolidated financial statements and related disclosures.</p> </div>
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2016
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.61
us-gaap Equity Method Investment Summarized Financial Information Net Income Loss
EquityMethodInvestmentSummarizedFinancialInformationNetIncomeLoss
230334000
us-gaap Depreciation And Amortization
DepreciationAndAmortization
177262000
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.60
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
117329000
us-gaap Costs And Expenses
CostsAndExpenses
5768916000
dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
4289000
us-gaap Cost Of Services
CostOfServices
4267846000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-72160000
us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
1356000000
us-gaap Equity Method Investment Dividends Or Distributions
EquityMethodInvestmentDividendsOrDistributions
14544000
us-gaap Proceeds From Sale Of Securities Operating Activities
ProceedsFromSaleOfSecuritiesOperatingActivities
62497000
us-gaap Revenues
Revenues
6054271000
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Before Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax
-85714000
us-gaap Interest Paid
InterestPaid
63420000
us-gaap Gain Loss On Sale Of Other Assets
GainLossOnSaleOfOtherAssets
73404000
us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
1142000
us-gaap Incremental Common Shares Attributable To Contingently Issuable Shares
IncrementalCommonSharesAttributableToContingentlyIssuableShares
3226936 shares
us-gaap Other Comprehensive Income Unrealized Gain Loss On Derivatives Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax
-4115000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
7097000
us-gaap Proceeds From Minority Shareholders
ProceedsFromMinorityShareholders
821000
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
21122000
us-gaap Payments To Acquire Interest In Joint Venture
PaymentsToAcquireInterestInJointVenture
27431000
us-gaap Operating Expenses
OperatingExpenses
1323808000
us-gaap Net Income Loss
NetIncomeLoss
203835000
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
4250000
us-gaap Payments For Proceeds From Tenant Allowance
PaymentsForProceedsFromTenantAllowance
-2339000
us-gaap Payments To Acquire Business Two Net Of Cash Acquired
PaymentsToAcquireBusinessTwoNetOfCashAcquired
16569000
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
4926000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
322249000
us-gaap Interest Expense
InterestExpense
71777000
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-39518000
us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
5529000
us-gaap Increase Decrease In Restricted Cash
IncreaseDecreaseInRestrictedCash
478000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
79058000
us-gaap Proceeds From Equity Method Investment Dividends Or Distributions Return Of Capital
ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital
93912000
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
21900000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
74672000
us-gaap Proceeds From Sale Of Mortgage Servicing Rights Msr
ProceedsFromSaleOfMortgageServicingRightsMSR
15071000
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-86467000
us-gaap Minority Interest Decrease From Distributions To Noncontrolling Interest Holders
MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
3517000
us-gaap Operating Income Loss
OperatingIncomeLoss
290174000
us-gaap Payments To Acquire Available For Sale Securities
PaymentsToAcquireAvailableForSaleSecurities
23984000
us-gaap Gains Losses On Sales Of Investment Real Estate
GainsLossesOnSalesOfInvestmentRealEstate
4819000
us-gaap Increase Decrease In Income Taxes Receivable
IncreaseDecreaseInIncomeTaxesReceivable
53095000
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
141488000
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
645000
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-111699000
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
160353000
us-gaap Investment Income Interest
InvestmentIncomeInterest
4525000
us-gaap Payments For Purchase Of Securities Operating Activities
PaymentsForPurchaseOfSecuritiesOperatingActivities
57985000
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
5112000
us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
-332454000
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
92230000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
114164000
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-210017000
us-gaap Other Comprehensive Income Other Net Of Tax
OtherComprehensiveIncomeOtherNetOfTax
-759000
us-gaap Proceeds From Sale Of Available For Sale Securities
ProceedsFromSaleOfAvailableForSaleSecurities
22061000
us-gaap Stockholders Equity Other
StockholdersEquityOther
-232000
us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
121618000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
337797887 shares
us-gaap Reclassification From Accumulated Other Comprehensive Income Current Period Net Of Tax
ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
-3476000
us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
5112000
us-gaap Restricted Stock Value Shares Issued Net Of Tax Withholdings
RestrictedStockValueSharesIssuedNetOfTaxWithholdings
1345000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
334534841 shares
dei Trading Symbol
TradingSymbol
CBG
us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
7097000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
814000
us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
3620000
us-gaap Proceeds From Repayments Of Short Term Debt
ProceedsFromRepaymentsOfShortTermDebt
-447000
us-gaap Profit Loss
ProfitLoss
208085000
us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
1200000000
us-gaap Share Based Compensation
ShareBasedCompensation
28554000
us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
4074000
us-gaap Payments To Minority Shareholders
PaymentsToMinorityShareholders
3517000
cbg Repayment Of Notes Payable On Real Estate Held For Sale And Under Development
RepaymentOfNotesPayableOnRealEstateHeldForSaleAndUnderDevelopment
4102000
cbg Proceeds From Notes Payable On Real Estate Held For Sale And Under Development
ProceedsFromNotesPayableOnRealEstateHeldForSaleAndUnderDevelopment
13315000
cbg Line Of Credit Facility Latest Expiration Date
LineOfCreditFacilityLatestExpirationDate
2017-06
cbg Minimum Coverage Ratio Of Earnings Before Interest Tax Depreciation And Amortization To Interest Expense
MinimumCoverageRatioOfEarningsBeforeInterestTaxDepreciationAndAmortizationToInterestExpense
2.00 pure
cbg Equity Method Investment Summarized Financial Information Operating Profit Loss
EquityMethodInvestmentSummarizedFinancialInformationOperatingProfitLoss
234775000
cbg Income Loss Before Net Interest Expense Write Off Of Financing Costs Income Taxes Depreciation And Amortization
IncomeLossBeforeNetInterestExpenseWriteOffOfFinancingCostsIncomeTaxesDepreciationAndAmortization
562513000
cbg Incremental Common Shares Attributable To Stock Options
IncrementalCommonSharesAttributableToStockOptions
36110 shares
cbg Maximum Leverage Ratio Of Debt To Earnings Before Interest Tax Depreciation And Amortization
MaximumLeverageRatioOfDebtToEarningsBeforeInterestTaxDepreciationAndAmortization
4.25 pure
cbg Minority Interest Increase From Contributions From Noncontrolling Interest Holders
MinorityInterestIncreaseFromContributionsFromNoncontrollingInterestHolders
821000
cbg Repayments Of Senior Term Loans
RepaymentsOfSeniorTermLoans
14375000
CY2015Q2 us-gaap Equity Method Investment Summarized Financial Information Revenue
EquityMethodInvestmentSummarizedFinancialInformationRevenue
307467000
CY2015Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.38
CY2015Q2 us-gaap Equity Method Investment Summarized Financial Information Net Income Loss
EquityMethodInvestmentSummarizedFinancialInformationNetIncomeLoss
-177125000
CY2015Q2 us-gaap Depreciation And Amortization
DepreciationAndAmortization
70605000
CY2015Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.37
CY2015Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
184845000
CY2015Q2 us-gaap Costs And Expenses
CostsAndExpenses
2168737000
CY2015Q2 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
8141000
CY2015Q2 us-gaap Cost Of Services
CostOfServices
1487974000
CY2015Q2 us-gaap Revenues
Revenues
2390506000
CY2015Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Before Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax
57508000
CY2015Q2 us-gaap Incremental Common Shares Attributable To Contingently Issuable Shares
IncrementalCommonSharesAttributableToContingentlyIssuableShares
3913275 shares
CY2015Q2 us-gaap Other Comprehensive Income Unrealized Gain Loss On Derivatives Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax
263000
CY2015Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-1069000
CY2015Q2 us-gaap Operating Expenses
OperatingExpenses
610158000
CY2015Q2 us-gaap Net Income Loss
NetIncomeLoss
125029000
CY2015Q2 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
8124000
CY2015Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
209627000
CY2015Q2 us-gaap Interest Expense
InterestExpense
26154000
CY2015Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
59833000
CY2015Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
228755000
CY2015Q2 us-gaap Gains Losses On Sales Of Investment Real Estate
GainsLossesOnSalesOfInvestmentRealEstate
6986000
CY2015Q2 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
237000
CY2015Q2 us-gaap Investment Income Interest
InvestmentIncomeInterest
1402000
CY2015Q2 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
6693000
CY2015Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
76474000
CY2015Q2 us-gaap Other Comprehensive Income Other Net Of Tax
OtherComprehensiveIncomeOtherNetOfTax
16000
CY2015Q2 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
192986000
CY2015Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
336154524 shares
CY2015Q2 us-gaap Reclassification From Accumulated Other Comprehensive Income Current Period Net Of Tax
ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
-1809000
CY2015Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
331999935 shares
CY2015Q2 us-gaap Profit Loss
ProfitLoss
133153000
CY2015Q2 cbg Equity Method Investment Summarized Financial Information Operating Profit Loss
EquityMethodInvestmentSummarizedFinancialInformationOperatingProfitLoss
-95947000
CY2015Q2 cbg Income Loss Before Net Interest Expense Write Off Of Financing Costs Income Taxes Depreciation And Amortization
IncomeLossBeforeNetInterestExpenseWriteOffOfFinancingCostsIncomeTaxesDepreciationAndAmortization
296860000
CY2015Q2 cbg Incremental Common Shares Attributable To Stock Options
IncrementalCommonSharesAttributableToStockOptions
241314 shares
CY2016Q2 us-gaap Equity Method Investment Summarized Financial Information Revenue
EquityMethodInvestmentSummarizedFinancialInformationRevenue
308982000
CY2016Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.36
CY2016Q2 us-gaap Equity Method Investment Summarized Financial Information Net Income Loss
EquityMethodInvestmentSummarizedFinancialInformationNetIncomeLoss
127554000
CY2016Q2 us-gaap Depreciation And Amortization
DepreciationAndAmortization
90268000
CY2016Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.36
CY2016Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
20842000
CY2016Q2 us-gaap Costs And Expenses
CostsAndExpenses
3024943000
CY2016Q2 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
1694000
CY2016Q2 us-gaap Cost Of Services
CostOfServices
2254233000
CY2016Q2 us-gaap Revenues
Revenues
3207537000
CY2016Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Before Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax
-102308000
CY2016Q2 us-gaap Incremental Common Shares Attributable To Contingently Issuable Shares
IncrementalCommonSharesAttributableToContingentlyIssuableShares
2976165 shares
CY2016Q2 us-gaap Other Comprehensive Income Unrealized Gain Loss On Derivatives Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax
-1206000
CY2016Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
3882000
CY2016Q2 us-gaap Operating Expenses
OperatingExpenses
680442000
CY2016Q2 us-gaap Net Income Loss
NetIncomeLoss
121668000
CY2016Q2 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
1777000
CY2016Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
187484000
CY2016Q2 us-gaap Interest Expense
InterestExpense
36987000
CY2016Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-100909000
CY2016Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
182594000
CY2016Q2 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
1574000
CY2016Q2 us-gaap Investment Income Interest
InvestmentIncomeInterest
3066000
CY2016Q2 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
34929000
CY2016Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
64039000
CY2016Q2 us-gaap Other Comprehensive Income Other Net Of Tax
OtherComprehensiveIncomeOtherNetOfTax
-702000
CY2016Q2 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
22536000
CY2016Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
338080641 shares
CY2016Q2 us-gaap Reclassification From Accumulated Other Comprehensive Income Current Period Net Of Tax
ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
-1733000
CY2016Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
335076746 shares
CY2016Q2 us-gaap Profit Loss
ProfitLoss
123445000
CY2016Q2 cbg Equity Method Investment Summarized Financial Information Operating Profit Loss
EquityMethodInvestmentSummarizedFinancialInformationOperatingProfitLoss
107060000
CY2016Q2 cbg Income Loss Before Net Interest Expense Write Off Of Financing Costs Income Taxes Depreciation And Amortization
IncomeLossBeforeNetInterestExpenseWriteOffOfFinancingCostsIncomeTaxesDepreciationAndAmortization
309896000
CY2016Q2 cbg Incremental Common Shares Attributable To Stock Options
IncrementalCommonSharesAttributableToStockOptions
27730 shares

Files In Submission

Name View Source Status
0001193125-16-676274-index-headers.html Edgar Link pending
0001193125-16-676274-index.html Edgar Link pending
0001193125-16-676274.txt Edgar Link pending
0001193125-16-676274-xbrl.zip Edgar Link pending
cbg-20160630.xml Edgar Link completed
cbg-20160630.xsd Edgar Link pending
cbg-20160630_cal.xml Edgar Link unprocessable
cbg-20160630_def.xml Edgar Link unprocessable
cbg-20160630_lab.xml Edgar Link unprocessable
cbg-20160630_pre.xml Edgar Link unprocessable
d222328d10q.htm Edgar Link pending
d222328dex311.htm Edgar Link pending
d222328dex312.htm Edgar Link pending
d222328dex32.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
g222328g51a04.jpg Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending